Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

20604 Press Releases
DateTitleCompany
18 Jul 18 Delphi Behavioral Health Group Announces Acquisition of Family Recovery Specialists Delphi Behavioral Health Group,
Published by
PR Newswire
18 Jul 18 Pall Corporation and KANEKA Corporation Expand Exclusive Distribution Agreement to Feature New KANEKA KanCapA™ 3G Protein A Chromatography Sorbents Pall Corporation,
Published by
PR Newswire
18 Jul 18 Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding Centivo,
Published by
PR Newswire
18 Jul 18 Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors Kodiak Sciences Inc.,
Published by
PR Newswire
18 Jul 18 Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR Transparency Market Research,
Published by
PR Newswire
18 Jul 18 Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017 Published by
GlobeNewswire
18 Jul 18 Orion Corporation's financial reporting and Annual General Meeting in 2019 Published by
GlobeNewswire
18 Jul 18 Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017 Esperite N.V.,
Published by
GlobeNewswire
18 Jul 18 Orion Corporation's financial reporting and Annual General Meeting in 2019 Orion Oyj,
Published by
GlobeNewswire
18 Jul 18 FDA grants Breakthrough Therapy Designation for Roche's Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC) F. Hoffmann-La Roche Ltd,
Published by
GlobeNewswire
18 Jul 18 Nathan Abbott Team Raising Funds to Help Families Who Have Kids Fighting Cancer Nathan Abbott Team,
Published by
PR Newswire
18 Jul 18 Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA Asceneuron,
Published by
PR Newswire
18 Jul 18 Rubius Therapeutics Announces Pricing of Initial Public Offering Published by
GlobeNewswire
18 Jul 18 R3 Stem Cell Now Offering Regenerative Therapy for Post Stroke Patients R3 Stem Cell,
Published by
PR Newswire
18 Jul 18 Dubai to Host WGO World Congress of Gastroenterology in 2021 (WCOG-2021) Emirates Gastroenterology & Hepatology Society,
Published by
PR Newswire
18 Jul 18 Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering Published by
GlobeNewswire
18 Jul 18 Kane Biotech Announces Closing of Loan Transaction Published by
GlobeNewswire
18 Jul 18 A Brand-New Website is Launching That Provides STD Testing Information and Resources STDtestinfo,
Published by
PR Newswire
17 Jul 18 CorVel Announces Quarterly Earnings Release Webcast Published by
GlobeNewswire
17 Jul 18 Actinium Forms Nuclear Medicine Focused Advisory Board to Facilitate Pipeline Clinical Development and Iomab-B Commercial Planning Published by
GlobeNewswire
17 Jul 18 ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 Published by
GlobeNewswire
17 Jul 18 Imagin Medical Reports Research Study Progress Published by
GlobeNewswire
17 Jul 18 Cara Therapeutics Announces Proposed Offering of Common Stock Published by
GlobeNewswire
17 Jul 18 AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares Published by
GlobeNewswire
17 Jul 18 ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 Erytech Pharma S.A.,
Published by
GlobeNewswire
17 Jul 18 ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call Published by
GlobeNewswire
17 Jul 18 Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors Published by
GlobeNewswire
17 Jul 18 Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund Published by
GlobeNewswire
17 Jul 18 CytomX Therapeutics Announces Closing of Public Offering of Common Stock Published by
GlobeNewswire
17 Jul 18 Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide Published by
GlobeNewswire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.